SuperGen, Inc. to Present at Thomas Weisel Partners Healthcare Conference September 5th
DUBLIN, Calif., Aug. 29 /PRNewswire-FirstCall/ -- SuperGen Inc. , a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced that James S. Manuso, Ph.D., President and Chief Executive Officer is scheduled to present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007, at the Four Seasons Hotel in Boston.
SuperGen's presentation at the Thomas Weisel Partners Healthcare Conference is scheduled to begin at 2:40 p.m. EDT. A live webcast of the presentation will be available on the investor relations section of the Company's Web site at www.supergen.com. The webcast will be archived for 90 days.
About SuperGen
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.
Contacts Timothy L. Enns SuperGen, Inc. SVP, Corporate Communications & Business Development Tel: (925) 560-0100 E-mail: tenns@supergen.com Mary M. Vegh SuperGen, Inc. Manager, Investor Relations Tel: (925) 560-2845 E-mail: mary.vegh@supergen.com
SuperGen Inc.CONTACT: Timothy L. Enns, SVP, Corporate Communications & BusinessDevelopment, +1-925-560-0100, tenns@supergen.com, or Mary M. Vegh, Manager,Investor Relations, +1-925-560-2845, mary.vegh@supergen.com, both ofSuperGen, Inc.
Web site: http://www.supergen.com/